(CRI) Creotech Instruments S.A. - Ratings and Ratios
Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock •
CRI: Aircraft, Spacecraft, Satellites, Computers, Navigation, Control, Data
Creotech Instruments S.A. (WAR:CRI) is a Poland-based company specializing in advanced technologies for the space, science, and defense sectors. Established in 2008 and headquartered in Piaseczno, the company has built a diverse portfolio that includes the production of aircraft and spacecraft components, electronic systems, telecommunications equipment, and precision measurement instruments. Creotech also engages in the generation and distribution of electricity and manufactures control and navigation apparatuses. The company’s expertise extends to specialized software development, engineering consultancy, and technical design services.
Creotech offers innovative solutions such as the GeomaticRemoteEye (GREy) platform, which provides advanced data visualization and analysis for topography, obstacles, and airspace. Additionally, the company operates CreoDIAS, a satellite data repository, and manages geoportals for spatial data applications. These technologies are integral to industries requiring precise geospatial intelligence, such as urban planning, environmental monitoring, and telecommunications infrastructure development.
As a key player in Poland’s aerospace and defense industry, Creotech Instruments S.A. has established itself through its commitment to R&D and innovation. The company’s products and services are not only utilized domestically but are also exported internationally, reflecting its growing global presence.
From a financial perspective, Creotech Instruments S.A. is valued at a market capitalization of 459.21M PLN. The company’s price-to-book (P/B) ratio stands at 5.98, indicating a premium valuation relative to its book value. However, the return on equity (RoE) is reported at -25.47, suggesting current profitability challenges. The forward P/E ratio is 0.00, indicating limited visibility into future earnings growth.
From a technical analysis standpoint, the stock is currently trading at 190.50 PLN, slightly above its 20-day simple moving average (SMA) of 189.77. The 50-day SMA is 180.53, and the 200-day SMA is 177.83, indicating a bullish trend over the medium term. The Average True Range (ATR) of 8.21 reflects moderate volatility.
Looking ahead, over the next three months, the stock is expected to trade within a range of 178.00 to 203.00 PLN. The immediate support level is at 177.83 (SMA 200), while the resistance level is at 203.00, based on historical price action. The relatively high P/S ratio of 13.58 suggests that the market expects strong revenue growth, which could drive the stock higher if realized.
Additional Sources for CRI Stock
CRI Stock Overview
Market Cap in USD | 135m |
Sector | Industrials |
Industry | Aerospace & Defense |
GiC Sub-Industry | Aerospace & Defense |
IPO / Inception |
CRI Stock Ratings
Growth Rating | 51.6 |
Fundamental | -47.6 |
Dividend Rating | 0.0 |
Rel. Strength | 9.71 |
Analysts | - |
Fair Price Momentum | 260.73 PLN |
Fair Price DCF | - |
CRI Dividends
No Dividends PaidCRI Growth Ratios
Growth Correlation 3m | 88.2% |
Growth Correlation 12m | 3.9% |
Growth Correlation 5y | 63.1% |
CAGR 5y | 40.98% |
CAGR/Max DD 5y | 0.86 |
Sharpe Ratio 12m | -0.08 |
Alpha | 32.29 |
Beta | -0.027 |
Volatility | 47.50% |
Current Volume | 22.2k |
Average Volume 20d | 4.3k |
As of April 16, 2025, the stock is trading at PLN 245.50 with a total of 22,196 shares traded.
Over the past week, the price has changed by +12.10%, over one month by +17.46%, over three months by +31.28% and over the past year by +36.39%.
Probably not. Based on ValueRay Fundamental Analyses, Creotech Instruments S.A. (WAR:CRI) is currently (April 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -47.56 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRI as of April 2025 is 260.73. This means that CRI is currently overvalued and has a potential downside of 6.2%.
Creotech Instruments S.A. has no consensus analysts rating.
According to ValueRays Forecast Model, CRI Creotech Instruments S.A. will be worth about 281.6 in April 2026. The stock is currently trading at 245.50. This means that the stock has a potential upside of +14.7%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 281.6 | 14.7% |